Viewing Study NCT01665794


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-25 @ 10:03 PM
Study NCT ID: NCT01665794
Status: COMPLETED
Last Update Posted: 2025-12-22
First Post: 2012-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor: University of Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords: